goeasy (GSY-T)

Current valuation finally lets him present it as a Top Pick idea. Expanding into credit cards. Sold off last year on CEO stepping down, but former (and excellent) CEO is helping in the interim. Balance sheet in great shape. Grows 20% a year, year in and year out. Trades at 7x PE, almost a distressed multiple, great entry point. Yield is 2.7%.

(Analysts’ price target is $235.53)

Keep holding if you have it. It is performing at the operating level and should outperform in 2025. It has been going sideways and is ready to break out.

We do not really have a specific reason here. It has had no company news in more than a month. Investors may be shifting to other hotter sectors. Trump has made comments about capping interest rates. The last quarter was not a blow-out. It's been more than a year since the last dividend hike. There is a CEO transition. At less than 10X earnings, we are not particularly concerned here. The company has adapted and thrived in all sorts of challenges and economic backdrops. We think 'now' is attractive, and at $150 (close to its prior low) very attractive. 
Unlock Premium - Try 5i Free

One of the best compounders in Canada. Tremendous management team, confident they'll find a capable CEO. Very strong operations. Organic growth rate has been good. Undemanding valuation. Well-developed risk management. Good hold for years to come.

Alternative lender. Headwind in Canada because of interest rate it's allowed to charge on loans, but those issues are mostly in the past. Instead, he's recently been buying PRL.

The banks lending Canadian lending, but forces like immigration favour companies like this. But their CEO left suddenly. It's been a nice bet for 15 as rates declined, but now now. Wait and see. Don't sell, but it could be a buy. It will be choppy.

Management issues a concern, but company very strong. Credit lending very good. Earnings expected to grow. Price to growth very good. Would recommend buying. 

Long time investor. Has owned for over 10 years. Recent share price weakness a good time to buy. Market has oversold some of the recent  announcements. Expecting loan book to grow to $6 billion. $30/share earnings not out of the question. A 6x earnings multiple would imply a ~$180 share price. 

It is a non-bank credit company. If you're looking for a specialty finance company there are a number of larger more mature ones out there. This one has too much volatility for him.

Continues to be a super-strong company. In the face of uncertainty and adversity, continues to move higher. Earnings and dividend continue to grow. One concern is what happens if there's a significant slowdown, (as lots of their loans are unsecured)? Loan loss numbers just get better and better.

Robust cashflow, consistent revenue growth. Company looks pretty strong. He'd like to see it demonstrate consistent earnings growth; if it did, he'd move it from Buy to Strong Buy. Don't let short-term performance dissuade you on this one.

GSY posted EPS of $4.1 vs $4.03 expected. Revenues were $378 mln vs $373 mln expected. Revenue view for the full year looks in line with expectations as well with the longer-term growth guidance increased. Revenue and EPS were up 25% and loan growth was up 37%. Overall we don't see a whole lot to pick on here. 
Unlock Premium - Try 5i Free